ADT-话题@MedSci

#ADT#

25篇内容 | 1689人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2205363, encodeId=68eb2205363e7, content=<a href='/topic/show?id=dd832018bd' target=_blank style='color:#2F92EE;'>#ADT#</a> <a href='/topic/show?id=d4cc80e128f' target=_blank style='color:#2F92EE;'>#联合治疗#</a> <a href='/topic/show?id=7529114596e8' target=_blank style='color:#2F92EE;'>#转移性激素敏感型前列腺癌#</a>, objectTitle=JAMA Oncol | 转移性激素敏感前列腺癌及其联合治疗结果, objectType=article, longId=826179, objectId=e9b98261e9fb, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240516/1715866244426_6145188.jpg, objectUrl=/article/show_article.do?id=e9b98261e9fb, replyNumber=0, likeNumber=136, createdTime=2024-05-18, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=e9b98261e9fb, moduleTitle=JAMA Oncol | 转移性激素敏感前列腺癌及其联合治疗结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e9b98261e9fb)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1477974, encodeId=d99e14e7974be, content=<a href='/topic/show?id=dd832018bd' target=_blank style='color:#2F92EE;'>#ADT#</a>, objectTitle=Lancet Oncol：艾瑞恩 vs 比卡鲁胺联合ADT治疗转移性激素阳性前列腺癌, objectType=article, longId=738668, objectId=be84e3866836, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=be84e3866836, replyNumber=0, likeNumber=103, createdTime=2022-09-10, rootId=0, userName=124984e7m85暂无昵称, userId=87be7387847, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=be84e3866836, moduleTitle=Lancet Oncol：艾瑞恩 vs 比卡鲁胺联合ADT治疗转移性激素阳性前列腺癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=be84e3866836)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1477973, encodeId=e0cd14e79737c, content=<a href='/topic/show?id=dd832018bd' target=_blank style='color:#2F92EE;'>#ADT#</a>, objectTitle=Cardiovasc Diabetol：在退伍军人糖尿病试验(VADT)中，低空腹c肽水平与心血管风险、随访时血糖变化和严重低血糖相关, objectType=article, longId=293433, objectId=affd2934339d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=affd2934339d, replyNumber=0, likeNumber=83, createdTime=2022-01-06, rootId=0, userName=124984e7m85暂无昵称, userId=87be7387847, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=affd2934339d, moduleTitle=Cardiovasc Diabetol：在退伍军人糖尿病试验(VADT)中，低空腹c肽水平与心血管风险、随访时血糖变化和严重低血糖相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=affd2934339d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1477972, encodeId=51a214e7972f7, content=<a href='/topic/show?id=dd832018bd' target=_blank style='color:#2F92EE;'>#ADT#</a>, objectTitle=运动不光防癌，还能助力接受ADT的患者抑制前列腺癌！, objectType=article, longId=218502, objectId=0c082185023a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0c082185023a, replyNumber=0, likeNumber=80, createdTime=2021-10-14, rootId=0, userName=124984e7m85暂无昵称, userId=87be7387847, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0c082185023a, moduleTitle=运动不光防癌，还能助力接受ADT的患者抑制前列腺癌！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0c082185023a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1477971, encodeId=1b6414e79717a, content=<a href='/topic/show?id=dd832018bd' target=_blank style='color:#2F92EE;'>#ADT#</a>, objectTitle=J Clin Oncol：放疗(RT)和雄激素剥夺疗法(ADT)联合或不联合多西他赛治疗非转移性的不良风险前列腺癌的疗效:一项前瞻性随机研究, objectType=article, longId=213679, objectId=ac592136e99d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ac592136e99d, replyNumber=0, likeNumber=117, createdTime=2021-07-05, rootId=0, userName=124984e7m85暂无昵称, userId=87be7387847, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ac592136e99d, moduleTitle=J Clin Oncol：放疗(RT)和雄激素剥夺疗法(ADT)联合或不联合多西他赛治疗非转移性的不良风险前列腺癌的疗效:一项前瞻性随机研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ac592136e99d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1477970, encodeId=b93814e7970b5, content=<a href='/topic/show?id=dd832018bd' target=_blank style='color:#2F92EE;'>#ADT#</a>, objectTitle=J Clin Oncol：阿帕鲁胺联合ADT可有效改善转移性去势敏感性前列腺癌的预后, objectType=article, longId=210697, objectId=96c221069ef7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=96c221069ef7, replyNumber=0, likeNumber=109, createdTime=2021-05-02, rootId=0, userName=124984e7m85暂无昵称, userId=87be7387847, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=96c221069ef7, moduleTitle=J Clin Oncol：阿帕鲁胺联合ADT可有效改善转移性去势敏感性前列腺癌的预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=96c221069ef7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1477969, encodeId=0fca14e7969ab, content=<a href='/topic/show?id=dd832018bd' target=_blank style='color:#2F92EE;'>#ADT#</a>, objectTitle=Clini cancer research：ADT联合Cy/GVAX治疗对前列腺肿瘤微环境T细胞浸润的影响, objectType=article, longId=196990, objectId=f9b4196990c1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f9b4196990c1, replyNumber=0, likeNumber=85, createdTime=2020-07-05, rootId=0, userName=124984e7m85暂无昵称, userId=87be7387847, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f9b4196990c1, moduleTitle=Clini cancer research：ADT联合Cy/GVAX治疗对前列腺肿瘤微环境T细胞浸润的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f9b4196990c1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1477968, encodeId=cc9114e796832, content=<a href='/topic/show?id=dd832018bd' target=_blank style='color:#2F92EE;'>#ADT#</a>, objectTitle=Clinical Cancer Res：Cabozantinib联合ADT治疗激素幼稚性转移性前列腺癌, objectType=article, longId=189552, objectId=e06a189552a1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e06a189552a1, replyNumber=0, likeNumber=90, createdTime=2020-03-10, rootId=0, userName=124984e7m85暂无昵称, userId=87be7387847, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e06a189552a1, moduleTitle=Clinical Cancer Res：Cabozantinib联合ADT治疗激素幼稚性转移性前列腺癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e06a189552a1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1477967, encodeId=6e6614e79678b, content=<a href='/topic/show?id=dd832018bd' target=_blank style='color:#2F92EE;'>#ADT#</a>, objectTitle=Lancet oncol：ADT疗法联合醋酸阿比特龙和强的松明显高危型转移性前列腺癌患者的总体存活期, objectType=article, longId=164282, objectId=b041164282af, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b041164282af, replyNumber=0, likeNumber=78, createdTime=2019-04-16, rootId=0, userName=124984e7m85暂无昵称, userId=87be7387847, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b041164282af, moduleTitle=Lancet oncol：ADT疗法联合醋酸阿比特龙和强的松明显高危型转移性前列腺癌患者的总体存活期, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b041164282af)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1477966, encodeId=4e3714e79668e, content=<a href='/topic/show?id=dd832018bd' target=_blank style='color:#2F92EE;'>#ADT#</a>, objectTitle=III期临床试验证明恩杂鲁胺与雄激素剥夺疗法（ADT）联合使用明显改善转移性前列腺癌的存活率, objectType=article, longId=160414, objectId=ea1416041497, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ea1416041497, replyNumber=0, likeNumber=96, createdTime=2019-02-20, rootId=0, userName=124984e7m85暂无昵称, userId=87be7387847, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ea1416041497, moduleTitle=III期临床试验证明恩杂鲁胺与雄激素剥夺疗法（ADT）联合使用明显改善转移性前列腺癌的存活率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ea1416041497)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1477965, encodeId=110714e796572, content=<a href='/topic/show?id=dd832018bd' target=_blank style='color:#2F92EE;'>#ADT#</a>, objectTitle=Prostate Cancer P D：EBRT附加或者不附加ADT在前列腺癌治疗中的实践模式, objectType=article, longId=148813, objectId=89741488137a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=89741488137a, replyNumber=0, likeNumber=127, createdTime=2018-09-15, rootId=0, userName=124984e7m85暂无昵称, userId=87be7387847, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=89741488137a, moduleTitle=Prostate Cancer P D：EBRT附加或者不附加ADT在前列腺癌治疗中的实践模式, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=89741488137a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1477964, encodeId=968214e79646a, content=<a href='/topic/show?id=dd832018bd' target=_blank style='color:#2F92EE;'>#ADT#</a>, objectTitle=J Urol：促性腺激素释放激素基因编码多态性与ADT期间血清睾酮水平之间的联系及与转移性前列腺癌预后的关系。, objectType=article, longId=114450, objectId=30db1144504e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=30db1144504e, replyNumber=0, likeNumber=105, createdTime=2017-09-29, rootId=0, userName=124984e7m85暂无昵称, userId=87be7387847, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=30db1144504e, moduleTitle=J Urol：促性腺激素释放激素基因编码多态性与ADT期间血清睾酮水平之间的联系及与转移性前列腺癌预后的关系。, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=30db1144504e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1477963, encodeId=079814e7963e1, content=<a href='/topic/show?id=dd832018bd' target=_blank style='color:#2F92EE;'>#ADT#</a>, objectTitle=JCO：雄激素剥夺治疗(ADT)对于前列腺癌老年患者来说，没有增加AD风险，对痴呆症也没有任何有意义的风险！, objectType=article, longId=111019, objectId=f209111019fe, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f209111019fe, replyNumber=0, likeNumber=98, createdTime=2017-08-28, rootId=0, userName=124984e7m85暂无昵称, userId=87be7387847, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f209111019fe, moduleTitle=JCO：雄激素剥夺治疗(ADT)对于前列腺癌老年患者来说，没有增加AD风险，对痴呆症也没有任何有意义的风险！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f209111019fe)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1477962, encodeId=f38214e7962de, content=<a href='/topic/show?id=dd832018bd' target=_blank style='color:#2F92EE;'>#ADT#</a>, objectTitle=黑人前列腺癌患者慎用ADT疗法治疗, objectType=article, longId=75507, objectId=32eae5507d7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=32eae5507d7, replyNumber=0, likeNumber=122, createdTime=2016-08-21, rootId=0, userName=124984e7m85暂无昵称, userId=87be7387847, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=32eae5507d7, moduleTitle=黑人前列腺癌患者慎用ADT疗法治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=32eae5507d7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1477961, encodeId=adda14e796158, content=<a href='/topic/show?id=dd832018bd' target=_blank style='color:#2F92EE;'>#ADT#</a>, objectTitle=JCO：接受ADT疗法的前列腺癌患者易患阿尔茨海默症, objectType=article, longId=60396, objectId=d3a3603963a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d3a3603963a, replyNumber=0, likeNumber=53, createdTime=2015-12-10, rootId=0, userName=124984e7m85暂无昵称, userId=87be7387847, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d3a3603963a, moduleTitle=JCO：接受ADT疗法的前列腺癌患者易患阿尔茨海默症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d3a3603963a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1477960, encodeId=737e14e7960f4, content=<a href='/topic/show?id=dd832018bd' target=_blank style='color:#2F92EE;'>#ADT#</a>, objectTitle=NEJM：多西他赛加ADT治疗显著延长转移性前列腺癌患者的总生存期, objectType=article, longId=54489, objectId=7cf754489be, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7cf754489be, replyNumber=0, likeNumber=78, createdTime=2015-08-07, rootId=0, userName=124984e7m85暂无昵称, userId=87be7387847, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7cf754489be, moduleTitle=NEJM：多西他赛加ADT治疗显著延长转移性前列腺癌患者的总生存期, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7cf754489be)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1477959, encodeId=21f814e79595b, content=<a href='/topic/show?id=dd832018bd' target=_blank style='color:#2F92EE;'>#ADT#</a>, objectTitle=ONF：对ADT治疗的前列腺癌患者如何减少静坐行为, objectType=article, longId=53148, objectId=3be953148e4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3be953148e4, replyNumber=0, likeNumber=156, createdTime=2015-07-11, rootId=0, userName=124984e7m85暂无昵称, userId=87be7387847, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3be953148e4, moduleTitle=ONF：对ADT治疗的前列腺癌患者如何减少静坐行为, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3be953148e4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1477958, encodeId=d3eb14e795820, content=<a href='/topic/show?id=dd832018bd' target=_blank style='color:#2F92EE;'>#ADT#</a>, objectTitle=ONF：耐冲击运动对进行ADT治疗的前列腺癌患者有何好处？, objectType=article, longId=52869, objectId=126f528699a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=126f528699a, replyNumber=0, likeNumber=79, createdTime=2015-07-05, rootId=0, userName=124984e7m85暂无昵称, userId=87be7387847, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=126f528699a, moduleTitle=ONF：耐冲击运动对进行ADT治疗的前列腺癌患者有何好处？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=126f528699a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1477957, encodeId=554314e7957d8, content=<a href='/topic/show?id=dd832018bd' target=_blank style='color:#2F92EE;'>#ADT#</a>, objectTitle=ASCO 2015：高危或者转移性前列腺癌ADT联合化疗显生存优势（STAMPEDE研究）, objectType=article, longId=51404, objectId=f4c251404aa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f4c251404aa, replyNumber=0, likeNumber=76, createdTime=2015-05-31, rootId=0, userName=124984e7m85暂无昵称, userId=87be7387847, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f4c251404aa, moduleTitle=ASCO 2015：高危或者转移性前列腺癌ADT联合化疗显生存优势（STAMPEDE研究）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f4c251404aa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1477956, encodeId=a46c14e7956bc, content=<a href='/topic/show?id=dd832018bd' target=_blank style='color:#2F92EE;'>#ADT#</a>, objectTitle=ASCO 2014：ADT+多西他赛延长转移性前列腺癌总生存期（OS）, objectType=article, longId=35750, objectId=89fe35e50d4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=89fe35e50d4, replyNumber=0, likeNumber=88, createdTime=2014-06-04, rootId=0, userName=124984e7m85暂无昵称, userId=87be7387847, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=89fe35e50d4, moduleTitle=ASCO 2014：ADT+多西他赛延长转移性前列腺癌总生存期（OS）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=89fe35e50d4)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

ADT

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#ADT# #联合治疗# #转移性激素敏感型前列腺癌#

JAMA Oncol | 转移性激素敏感前列腺癌及其联合治疗结果

2024-05-18发表于上海

124984e7m85暂无昵称 (审核中...)

前往app查看评论内容

#ADT#

Lancet Oncol：艾瑞恩 vs 比卡鲁胺联合ADT治疗转移性激素阳性前列腺癌

2022-09-10

124984e7m85暂无昵称 (审核中...)

前往app查看评论内容

#ADT#

Cardiovasc Diabetol：在退伍军人糖尿病试验(VADT)中，低空腹c肽水平与心血管风险、随访时血糖变化和严重低血糖相关

2022-01-06

124984e7m85暂无昵称 (审核中...)

前往app查看评论内容

#ADT#

运动不光防癌，还能助力接受ADT的患者抑制前列腺癌！

2021-10-14

124984e7m85暂无昵称 (审核中...)

前往app查看评论内容

#ADT#

J Clin Oncol：放疗(RT)和雄激素剥夺疗法(ADT)联合或不联合多西他赛治疗非转移性的不良风险前列腺癌的疗效:一项前瞻性随机研究

2021-07-05

124984e7m85暂无昵称 (审核中...)

前往app查看评论内容

#ADT#

J Clin Oncol：阿帕鲁胺联合ADT可有效改善转移性去势敏感性前列腺癌的预后

2021-05-02

124984e7m85暂无昵称 (审核中...)

前往app查看评论内容

#ADT#

Clini cancer research：ADT联合Cy/GVAX治疗对前列腺肿瘤微环境T细胞浸润的影响

2020-07-05

124984e7m85暂无昵称 (审核中...)

前往app查看评论内容

#ADT#

Clinical Cancer Res：Cabozantinib联合ADT治疗激素幼稚性转移性前列腺癌

2020-03-10

124984e7m85暂无昵称 (审核中...)

前往app查看评论内容

#ADT#

Lancet oncol：ADT疗法联合醋酸阿比特龙和强的松明显高危型转移性前列腺癌患者的总体存活期

2019-04-16

124984e7m85暂无昵称 (审核中...)

前往app查看评论内容

#ADT#

III期临床试验证明恩杂鲁胺与雄激素剥夺疗法（ADT）联合使用明显改善转移性前列腺癌的存活率

2019-02-20

124984e7m85暂无昵称 (审核中...)

前往app查看评论内容

#ADT#

Prostate Cancer P D：EBRT附加或者不附加ADT在前列腺癌治疗中的实践模式

2018-09-15

124984e7m85暂无昵称 (审核中...)

前往app查看评论内容

#ADT#

J Urol：促性腺激素释放激素基因编码多态性与ADT期间血清睾酮水平之间的联系及与转移性前列腺癌预后的关系。

2017-09-29

124984e7m85暂无昵称 (审核中...)

前往app查看评论内容

#ADT#

JCO：雄激素剥夺治疗(ADT)对于前列腺癌老年患者来说，没有增加AD风险，对痴呆症也没有任何有意义的风险！

2017-08-28

124984e7m85暂无昵称 (审核中...)

前往app查看评论内容

#ADT#

黑人前列腺癌患者慎用ADT疗法治疗

2016-08-21

124984e7m85暂无昵称 (审核中...)

前往app查看评论内容

#ADT#

JCO：接受ADT疗法的前列腺癌患者易患阿尔茨海默症

2015-12-10

124984e7m85暂无昵称 (审核中...)

前往app查看评论内容

#ADT#

NEJM：多西他赛加ADT治疗显著延长转移性前列腺癌患者的总生存期

2015-08-07

124984e7m85暂无昵称 (审核中...)

前往app查看评论内容

#ADT#

ONF：对ADT治疗的前列腺癌患者如何减少静坐行为

2015-07-11

124984e7m85暂无昵称 (审核中...)

前往app查看评论内容

#ADT#

ONF：耐冲击运动对进行ADT治疗的前列腺癌患者有何好处？

2015-07-05

124984e7m85暂无昵称 (审核中...)

前往app查看评论内容

#ADT#

ASCO 2015：高危或者转移性前列腺癌ADT联合化疗显生存优势（STAMPEDE研究）

2015-05-31

124984e7m85暂无昵称 (审核中...)

前往app查看评论内容

#ADT#

ASCO 2014：ADT+多西他赛延长转移性前列腺癌总生存期（OS）

2014-06-04

科室
- - 订阅+
  - 更多科室
工具
服务